Phase 3 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with metastatic pancreatic adenocarcinoma (a specific type of pancreatic cancer that has spread to other parts of the body), confirmed within the last 12 weeks before screening
- People whose general physical health and ability to carry out daily activities meets a certain standard, rated 0 or 1 on a scale used by doctors called the ECOG scale (meaning fully active or restricted in strenuous activity but able to do light work)
- People who have not yet received any systemic anti-cancer treatment (such as chemotherapy) for this condition
- People who have at least one area of cancer that can be measured on a scan, based on standard medical guidelines called RECIST v1.1
- People whose liver, kidneys, blood clotting, and other organ functions meet the levels required by the trial protocol
Who may not be able to join:
- People who are unable to swallow tablets or capsules taken by mouth
- People whose pancreatic cancer is a different type, specifically squamous, adenosquamous, neuroendocrine (including carcinoid or islet cell), or acinar carcinoma
- People whose cancer has not spread beyond the local area (locally advanced disease only, without spread to other parts of the body)
- People who have cancer that has spread to the brain or central nervous system, where those metastases are causing symptoms, have not been treated, or are actively getting worse
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 860-321-1302
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Overall Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.